Be invited to scroll down for detailed information regarding the Evotec SE share, ranging from basic share data to our dividend policy.
Be invited to scroll down for detailed information regarding the Evotec SE share, ranging from basic share data to our dividend policy.
Ticker symbol:
Frankfurt Stock Exchange: EVT
OTC Markets, OTCBB: EVTCY
Bloomberg Xetra: EVT GY Equity
Bloomberg OTC Markets, OTCBB: EVTCY US Equity
Reuters Xetra: EVTG.DE
Stock exchange:
Frankfurt Stock Exchange
OTC Markets, OTCBB
Segment:
Prime Standard
Index:
MDAX, TecDAX, Prime All Share, LTecDAX, Technology All Share, CDAX
Designated sponsor:
ODDO SEYDLER BANK AG
Paying agent:
Deutsche Bank AG, Frankfurt am Main
Number of shares issued:
164,552,603 ordinary bearer shares
Nominal capital:
€ 164,552,603
Security identification numbers: Frankfurt Stock Exchange (ordinary bearer shares) ISIN: DE0005664809 OTC Markets, OTCBB (American Depositary Shares, ADSs) CUSIP: 30050E105 ISIN: US30050E1055 |
|
Ticker symbol: Bloomberg Xetra: EVT GY Equity Bloomberg OTC Markets, OTCBB: EVTCY US Equity |
|
Stock exchange: |
|
Segment: |
|
Index: |
|
Designated sponsor: |
|
Paying agent: |
|
Number of shares issued: |
|
Nominal capital: |
High (26 July): € 26.91 |
|
Low (02 January): € 17.30 |
|
Opening Price: € 17.30 |
|
Closing Price: € 23.05 |
|
Weighted average number of shares outstanding: 149,725,607 |
|
Total number of shares outstanding as at 31 Dec: 150,902,578 |
|
Average daily trading volume (all exchanges): 1,126,943 |
|
Market capitalisation as at 31 Dec: € 3,474.6 m |
|
Earnings per share (diluted/basic): € 0.25/€ 0.25 |
|
Dividend per share: € 0.00 |
On 26 February 2021, the number of total voting rights amounts to 164.552.603.
Under the German Securities Trading Act (Wertpapierhandelsgesetz, WpHG), shareholders of a listed German company are required to notify the Company and the German Federal Financial Supervisory Authority (BaFin) of any change to the voting interest in Evotec SE whenever it reaches, exceeds or falls below specified thresholds (3%, 5%, 10%, 15%, 20%, 25%, 30%, 50% or 75% of the voting rights). Evotec’s voting rights announcements can be found at dgap.de.
Five major shareholders, Novo Holdings A/S, ROI Verwaltungsgesellschaft mbH/Roland Oetker, T. Rowe Price Group, Inc., Mubadala Investment Company und Allianz Global Investors currently hold more than 3% of the shares of Evotec SE. The free float according to the definition of the Frankfurt Stock Exchange is approx. 62% according to our estimates (Evotec: 02|2021).
Evotec is monitored and assessed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Evotec’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Evotec or its management. Evotec does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. Evotec has no obligation to update or supplement the above information and makes no representation or warranty as to the accuracy and completeness of this list.
Copies of the research reports of the above-named analysts must be obtained directly from the analysts or their employers. Evotec is not able to publish the research reports due to legal considerations.
*All data not adjusted for stock split of 18 August 2000
Payment of dividends is dependent upon Evotec financial situation and liquidity requirements, the general market conditions and statutory, tax and regulatory requirements. Evotec currently intends to retain any potential future profits and reinvest them in the Company’s further growth strategy to even better leverage long-term growth and sustainability.